DAIC

OCTOBER 2, 2024

Director of the Hypertrophic Cardiomyopathy Center at the Lahey Hospital and Medical Center. These data elaborate on the primary results from SEQUOIA-HCM and further inform the relevance to clinical practice of aficamten as a next-in-class cardiac myosin inhibitor for adult patients with obstructive HCM.” References: Maron M, et al.

Cardiomyopathy 40

Cardiomyopathy Sudden Cardiac Death Biomarkers Heart Failure 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 7, 2024

Abstract Introduction Despite advancements in implantable cardioverter-defibrillator (ICD) technology, sudden cardiac death (SCD) remains a persistent public health concern. Time periods were chosen based on the establishment of the Arrhythmia Service in 2011. 001) and the combined outcome ( p  = .009).

Defibrillator 40

Defibrillator Sudden Cardiac Death Tachycardia Public Health 40

Dr. S. Venkatesan MD

MARCH 19, 2024

Brandão M, Desmoplakin Cardiomyopathy: Comprehensive Review of an Increasingly Recognized Entity. He said a screening test called cardiac-arrhythmic genome analysis is available in certain European centers. The role of the molecular autopsy in sudden cardiac death in young individuals. J Clin Med. Semsarian, C.

Arrhythmia 52

Arrhythmia Sudden Cardiac Death Electrophysiology Cardiomyopathy 52

EMS 12-Lead

APRIL 28, 2022

In most cases, rather, the culprit is gross ischemia due to myocardial infarction, cardiomyopathy, or advanced coronary artery disease. Pleomorphic ventricular tachycardia and risk for sudden cardiac death. genes implicated in congenital Long QT syndrome, such as SCN5A and KCNQ1). [1-3, Elsevier: Philadelphia, PA. [7]

Tachycardia 52

Tachycardia AFIB Arrhythmia Coronary Artery Bypass Graft 52